Immunocore Holdings plc - Ordinary shares (IMCR)

Historical Holders from Q1 2021 to Q4 2025

Type / Class
Equity / Ordinary shares
Symbol
IMCR on Nasdaq
Shares outstanding
49,942,911
Price per share
$34.71
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
49,180,519
Total reported value
$1,786,666,273
% of total 13F portfolios
0%
Share change
+1,344,896
Value change
+$50,908,661
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
131
Price from insider filings
$40.14
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Immunocore Holdings plc - Ordinary shares (IMCR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
T. Rowe Price Investment Management, Inc. 14% $182,077,941 7,051,818 T. Rowe Price Investment Management, Inc. 31 Mar 2025
WELLINGTON MANAGEMENT GROUP LLP 10% +12% $152,909,031 +$18,391,571 5,132,898 +14% Wellington Management Group LLP 31 Jul 2025
Jallal Bahija 8.2% $116,012,849 4,493,139 Jallal Bahija 31 Dec 2024
PRIMECAP MANAGEMENT CO/CA/ 7.5% +44% $121,616,824 +$35,582,772 3,772,234 +41% PRIMECAP MANAGEMENT CO/CA/ 30 Jun 2025
Bellevue Group AG 5.6% $101,607,853 2,796,803 Bellevue Group AG 20 Aug 2025
TANG CAPITAL MANAGEMENT LLC 5.2% $94,662,520 2,605,608 TANG CAPITAL MANAGEMENT, LLC 17 Oct 2025
As of 30 Sep 2025, Immunocore Holdings plc - Ordinary shares (IMCR) has 131 institutional shareholders filing 13F forms. They hold 49,180,519 shares. of 49,942,911 outstanding shares (98%) .

Top 25 institutional shareholders own 90% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
T. Rowe Price Investment Management, Inc. 14% 7,063,896 -0.05% 0.16% $256,632,000
RTW INVESTMENTS, LP 9.8% 4,869,798 0% 2.2% $176,919,761
WELLINGTON MANAGEMENT GROUP LLP 9.6% 4,780,889 +13% 0.03% $173,689,698
FMR LLC 8.9% 4,420,403 -9% 0.01% $160,593,235
PRIMECAP MANAGEMENT CO/CA/ 7.5% 3,754,560 -0.45% 0.1% $136,403,165
Bellevue Group AG 5.6% 2,796,803 +15% 2.1% $101,607,853
BAKER BROS. ADVISORS LP 4.7% 2,322,656 0% 0.61% $84,382,092
TANG CAPITAL MANAGEMENT LLC 4.6% 2,305,608 +9.5% 3.2% $83,762,739
Deep Track Capital, LP 3.6% 1,800,000 0% 1.8% $65,394,000
BVF INC/IL 3.2% 1,574,288 +54% 2.3% $57,193,883
MILLENNIUM MANAGEMENT LLC 2.5% 1,265,965 +358% 0.04% $45,992,508
PRICE T ROWE ASSOCIATES INC /MD/ 2% 1,016,771 +1.1% 0% $36,940,000
Kynam Capital Management, LP 2% 1,009,267 +3.4% 2.7% $36,666,670
Logos Global Management LP 1.7% 850,000 +48% 3.1% $30,880,500
ARMISTICE CAPITAL, LLC 1.6% 824,000 +22% 0.94% $29,935,920
Fiera Capital Corp 1.6% 795,157 -2.2% 0.09% $28,888,053
Point72 Asset Management, L.P. 1.1% 535,831 -35% 0.04% $19,466,740
Caption Management, LLC 0.93% 463,662 +158% 0.98% $16,844,840
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 0.89% 442,398 -0.76% 0% $16,072,319
PRINCIPAL FINANCIAL GROUP INC 0.82% 411,409 -9.6% 0.01% $14,946,489
Frazier Life Sciences Management, L.P. 0.77% 384,782 0% 0.42% $13,979,130
Hudson Bay Capital Management LP 0.67% 333,558 -3.6% 0.07% $12,118,162
TWO SIGMA ADVISERS, LP 0.66% 330,000 -36% 0.02% $11,988,900
TD Asset Management Inc 0.58% 288,860 +0.91% 0.01% $10,494,284
Candriam S.C.A. 0.54% 269,729 +100% 0.05% $9,799,255

Institutional Holders of Immunocore Holdings plc - Ordinary shares (IMCR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 9,561 $332,308 +$35,772 3,471% 3
2025 Q3 49,180,519 $1,786,666,273 +$50,908,661 3,633% 131
2025 Q2 47,759,431 $1,498,675,257 +$17,984,717 3,138% 132
2025 Q1 47,287,653 $1,402,998,146 +$60,274,162 2,967% 115
2024 Q4 45,397,254 $1,339,170,351 -$4,700,092 2,950% 113
2024 Q3 45,275,292 $1,410,431,002 +$61,178,963 3,113% 129
2024 Q2 43,012,978 $1,457,966,231 -$100,415,189 3,389% 135
2024 Q1 41,210,539 $2,678,311,141 +$247,060,152 6,500% 153
2023 Q4 168,168 $11,489,238 +$5,431,098 6,832% 3
2023 Q3 36,920,468 $1,916,148,784 +$85,343,515 5,190% 123
2023 Q2 35,286,231 $2,114,539,636 +$164,445,131 5,996% 116
2023 Q1 32,686,114 $1,614,452,190 +$118,535,242 4,944% 107
2022 Q4 30,228,946 $1,725,187,126 +$251,722,518 5,707% 100
2022 Q3 26,348,834 $1,236,656,033 +$213,109,146 4,694% 80
2022 Q2 21,016,054 $783,633,369 +$55,802,507 3,730.92% 64
2022 Q1 19,739,703 $590,121,252 +$57,741,645 2,989.99% 57
2021 Q4 17,133,052 $586,618,000 +$22,048,630 3,423.96% 45
2021 Q3 16,654,128 $617,381,000 +$83,084,367 3,706.96% 46
2021 Q2 13,805,484 $538,110,000 +$9,423,884 3,905% 42
2021 Q1 14,110,965 $597,836,000 +$597,834,944 4,257.05% 41